[42, 43] In this respect, since we confirmed that MYCN exists as the most potent mutation in kidney cancer [38], we aimed to present a therapeutic option with the same effects as RNA interference, by using exosomes to carry a cargo of this microRNA. This evidence concerns the gene MYCN and kidney cancer.